Cytomegalovirus and Blood Transfusion

  • John D. Hamilton
Part of the Frontiers of Virology book series (FRVIROLOGY, volume 2)


This chapter summarizes the evidence that cytomegalovirus is present in certain cells in whole blood in both the active and latent state and that the virus can be transmitted in its latent state to a susceptible host by transfusion. Normal and immunosuppressed adults and newborn infant recipients are discussed as well as some methods of prevention.


Cytomegalovirus Infection Latent Virus Bone Marrow Donor Renal Allograft Recipient Serologic Status 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adler SP (1983) Transfusion-associated cytomegalovirus infections. Rev Infect Dis 5: 977–993PubMedCrossRefGoogle Scholar
  2. 2.
    Adler SP, Chandrika T, Lawrence L, Baggett J (1983) Cytomegalovirus infections in neonates acquired by blood transfusions. Pediatr Infect Dis 2: 114–118PubMedCrossRefGoogle Scholar
  3. 3.
    Adler SP, Baggett J, McVoy M (1985) Transfusion-associated cytomegalovirus infections in seropositive cardiac surgery patients. Lancet 2: 743–747PubMedCrossRefGoogle Scholar
  4. 4.
    Armstrong D, Ely M, Steger L (1971) Post-transfusion cytomegaloviremia and persistence of cytomegalovirus in blood. Infect Immun 3: 159–163PubMedGoogle Scholar
  5. 5.
    Armstrong JA, Tarr GC, Youngblood LA et al. (1976) Cytomegalovirus infection in children undergoing open-heart surgery. Yale J Biol Med 49: 83–91PubMedGoogle Scholar
  6. 6.
    Ballard RA, Drew WL, Hufnagle KG et al. (1979) Acquired cytomegalovirus infection in preterm infants. Am J Dis Child 133: 442–448Google Scholar
  7. 7.
    Bayer WL (1977) The effect of frozen blood on the relationship of cytomegalovirus and hepatitis virus to infection and disease. In: Dawson RB, Barnes A Jr (eds) Clinical and practical aspects of the use of frozen blood. American Association of Blood Banks, Washington, pp 133–145Google Scholar
  8. 8.
    Betts RF (1982) Cytomegalovirus infection in transplant patients. Prog Med Virol 28: 44–64PubMedGoogle Scholar
  9. 9.
    Betts RF, Freeman RB, Douglas RG Jr, Talley TE, Rundell B (1975) Transmission of cytomegalovirus infection with renal allograft. Kidney Int 8: 385–392PubMedCrossRefGoogle Scholar
  10. 10.
    Betts RF, Cestero RVM, Freeman RB, Douglas RC Jr (1979) Epidemiology of cytomegalovirus infection in end stage renal disease. J Med Virol 4: 89–96PubMedCrossRefGoogle Scholar
  11. 11.
    Bowden RA, Sayers M, Flournoy N et al. (1986) Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 314: 1006–1010PubMedCrossRefGoogle Scholar
  12. 12.
    Brady MT, Milam JD, Anderson DC et al. (1984) Use of deglycerolized red blood cells to prevent posttransfusion infection with cytomegalovirus in neonates. J Infect Dis 150: 334–339PubMedCrossRefGoogle Scholar
  13. 13.
    Braun WE, Nankervis G, Banowsky LH, Protiva D, Biekert E, McHenry MC (1976) A prospective study of cytomegalovirus infections in 75 renal allograft recipients. Proc Clin Dial Transplant Forum 6: 8–12PubMedGoogle Scholar
  14. 14.
    Brautigam AR, Dutko FJ, Olding LB, Oldstone MBA (1979) Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J Gen Virol 44: 349–359PubMedCrossRefGoogle Scholar
  15. 15.
    Caul EO, Clarke SKR, Mott MG et al. (1971) Cytomegalovirus infections after open heart surgery. Lancet 1: 777–781PubMedCrossRefGoogle Scholar
  16. 16.
    Chou S, Kim DY, Norman DJ (1987) Transmission of cytomegalovirus by pretransplant leukocyte transfusions in renal transplant candidates. J Infect Dis 155: 565–567PubMedCrossRefGoogle Scholar
  17. 17.
    Chou SW, Norman DJ (1988) The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients. Transplantation 46: 89–93PubMedCrossRefGoogle Scholar
  18. 18.
    Condie RM, O’Reilly RJ (1984) Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin: randomized trial in bone marrow transplant recipients. Am J Med 76: 134–141PubMedCrossRefGoogle Scholar
  19. 19.
    Diosi P, Moldovan E, Tomescu N (1969) Latent cytomegalovirus infection in blood donors. Br Med J 4: 660–662PubMedCrossRefGoogle Scholar
  20. 20.
    Embil JA, Folkins DF, Haldane EV et al. (1968) Cytomegalovirus infection following extra-corporeal circulation in children: a prospective study. Lancet 2: 1151–1155PubMedCrossRefGoogle Scholar
  21. 21.
    Fiala M, Chatterjee S (1982) The role of lymphocytes in infections due to Epstein-Barr virus and cytomegalovirus ( Letter ). J Infect Dis 146: 300–301Google Scholar
  22. 22.
    Foster KM, Jack I (1969) A prospective study of the role of cytomegalovirus in post-transfusion mononucleosis. N Engl J Med 280: 1311–1316PubMedCrossRefGoogle Scholar
  23. 23.
    Gadler H, Tillegard A, Groth CG (1982) Studies of cytomegalovirus infection in renal allograft recipients. I. Virus isolation. Scand J Infect Dis 14: 81–87Google Scholar
  24. 24.
    Garnett HM (1982) Isolation of human cytomegalovirus from peripheral blood T cells of renal transplant patients. J Lab Clin Med 99: 92–97PubMedGoogle Scholar
  25. 25.
    Gentry LO, Zeluff BJ (1986) Diagnosis and treatment of infection in cardiac transplant patients. Surg Clin North Am 66: 459–465PubMedGoogle Scholar
  26. 26.
    Hamilton JD (1982) Cytomegalovirus and immunity, vol. 12. Karger, BaselGoogle Scholar
  27. 27.
    Harnden DG, Elsdale TR, Young DE, Ross A (1967) The isolation of cytomegalovirus from peripheral blood. Blood 30: 120–125PubMedGoogle Scholar
  28. 28.
    Henle W, Henle G, Scriba M et al. (1970) Antibody responses to the Epstein-Barr virus and cytomegalovirus after open-heart and other surgery. N Engl J Med 282: 1068–1074PubMedCrossRefGoogle Scholar
  29. 29.
    Ho M (1982) Cytomegalovirus — biology and infection. Plenum, New YorkGoogle Scholar
  30. 30.
    Ho M, Suwansirikul S, Dowling JN, Youngblood LA, Armstrong JA (1975) The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med 293: 1109–1112PubMedCrossRefGoogle Scholar
  31. 31.
    Jackson JB, Orr HT, McCullough JJ, Jordan MC (1987) Failure to detect human cytomegalovirus DNA in IgM-seropositive blood donors by spot hybridization. J Infect Dis 156: 1013–1016PubMedCrossRefGoogle Scholar
  32. 32.
    Jesionek A, Kiolemenoglou B (1904) Über einen Befund von protozoenartigen Gebilden in den Organen eines hereditär-luetischen Fötus. MMW 51: 1905–1907Google Scholar
  33. 33.
    Kaariainen L, Klemola E, Paloheimo J (1966) Rise of cytomegalovirus antibodies in an infectious-mononucleosis-like syndrome after transfusion. Br Med J 1: 1270–1272PubMedCrossRefGoogle Scholar
  34. 34.
    Kaariainen L, Paloheimo J, Klemola E et al. (1966) Cytomegalovirus-mononucleosis: isolation of virus and demonstration of subclinical infections after blood transfusion in connection with open-heart surgery. Ann Med Exp Biol Fenn 44: 297–301PubMedGoogle Scholar
  35. 35.
    Klemola E, Kaariainen L (1965) Cytomegalovirus — a possible cause of a disease resembling infectious mononucleosis. Br Med J 2: 1099–1102PubMedCrossRefGoogle Scholar
  36. 36.
    Klemola E, von Essen R, Paloheimo J, Furuhjelm U (1969) Cytomegalovirus antibodies in donors of fresh blood to patients submitted to open-heart surgery. Scand J Infect Dis 1: 137–140PubMedGoogle Scholar
  37. 37.
    Kumar A, Nankervis GA, Cooper AR et al. (1980) Acquisition of cytomegalovirus infection in infants following exchange transfusion: a prospective study. Transfusion 20: 327–331PubMedCrossRefGoogle Scholar
  38. 38.
    Lamberson HV Jr, McMillian JA, Weiner LB et al. (1988) Prevention of transfusion-associated cytomegalovirus ( CMV) infection in neonates by screening blood donors for IgM to CMV. J Infect Dis 157: 820–823Google Scholar
  39. 39.
    Lang DJ, Hanshaw JB (1969) Cytomegalovirus infection and the postperfusion syndrome. N Engl J Med 280: 1145–1149PubMedCrossRefGoogle Scholar
  40. 40.
    Lang DJ, Ebert PA, Rodgers BM, Boggess HP, Rixse RS (1977) Reduction of postperfusion cytomegalovirus-infections following the use of leukocyte depleted blood. Transfusion 17: 391–395PubMedCrossRefGoogle Scholar
  41. 41.
    Lowenstein C (1907) Über protozoenartige Gebilde in den Organen von Kindern. Zentralbi Allg Pathol Pathol Anat 18: 513–518Google Scholar
  42. 42.
    Luban NL, Williams AE, MacDonald MG, Mikesell GT, Williams KM, Sacher RA (1987) Low incidence of acquired cytomegalovirus infection in neonates transfused with washed red blood cells. Am J Dis Child 141: 416–419PubMedGoogle Scholar
  43. 43.
    Luby JP, Burnett W, Hull AR, Ware AJ, Shorey JW, Peters PC (1974) Relationship between cytomegalovirus and hepatic function abnormalities in the period after renal transplant. J Infect Dis 129: 511–518PubMedCrossRefGoogle Scholar
  44. 44.
    Luthardt T, Siebert H, Losel I et al. (1971) Cytomegalievirus-Infektionen bei Kindern mit Blutaustauschtransfusion im Neugeborenenalter. Klin Wochenschr 49: 81–86PubMedCrossRefGoogle Scholar
  45. 45.
    Mackinnon S, Burnett AK, Crawford RJ, Cameron S, Leask BG, Sommerville RG (1988) Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation. J Clin Pathol 41: 948–950PubMedCrossRefGoogle Scholar
  46. 46.
    Martin DC, Katzenstein DA, Yu GSM, Jordan MC (1984) Cytomegalovirus viremia detected by molecular hybridization and electron microscopy. Ann Intern Med 100: 222–225PubMedGoogle Scholar
  47. 47.
    McCordock HA, Smith MG (1936) The visceral lesions produced in mice by the salivary gland virus of mice. J Exp Med 63: 303–310PubMedCrossRefGoogle Scholar
  48. 48.
    Medical Research Council (MRC) Working Party on Post-Transfusion (1974) Hepatitis report to the MRC Blood Transfusion Research Committee: Post-transfusion hepatitis in a London hospital: results of a two-year prospective study. J Hyg (Lond) 73: 173–188Google Scholar
  49. 49.
    Meyers JD, Leszczynski J, Zaia JA et al. (1983) Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 98: 442–446PubMedGoogle Scholar
  50. 50.
    Meyers JD, Flournoy N, Thomas ED (1986) Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153: 478–488PubMedCrossRefGoogle Scholar
  51. 51.
    Monif GRG, Daicoff GI, Flory LL (1976) Blood as a potential vehicle for the cytomegaloviruses. Am J Obstet Gynecol 126: 445–448PubMedGoogle Scholar
  52. 52.
    Murphy MF, Grint PC, Hardiman AE, Lister TA, Waters AH (1988) Use of leucocyte-poor blood components to prevent primary cytomegalovirus (CMV) infection in patients with acute leukaemia ( Letter ). Br J Haematol 70: 253–254Google Scholar
  53. 53.
    Nankervis GA (1976) Cytomegalovirus infections in the blood recipient. Yale J Biol Med 49: 13–15PubMedGoogle Scholar
  54. 54.
    Paloheimo JA, von Essen R, Klemola E, Kaariainen L, Siltanen P (1968) Subclinical cytomegalovirus infections and cytomegalovirus mononucleosis after open heart surgery. Am J Cardiol 22: 624–630PubMedCrossRefGoogle Scholar
  55. 55.
    Preiksaitis JK, Rosno S, Grumet C, Merigan TC (1983) Infections due to herpesviruses in cardiac transplant recipients: role of the donor heart and immunosuppressive therapy. J Infect Dis 147: 974–981PubMedCrossRefGoogle Scholar
  56. 56.
    Preiksaitis JK, Grumet FC, Smith WK, Merigan TC (1985) Transfusion-acquired cytomegalovirus infection in cardiac surgery patients. J Med Virol 15: 283–290PubMedCrossRefGoogle Scholar
  57. 57.
    Preiksaitis JK, Brown L, McKenzie M (1988) The risk of cytomegalovirus infection in seronegative transfusion recipients not receiving exogenenous immunosuppression. J Infect Dis 157: 523–529PubMedCrossRefGoogle Scholar
  58. 58.
    Preiksaitis JK, Brown L, McKenzie M (1988) Transfusion-acquired cytomegalovirus infection in neonates. A prospective study. Transfusion 28: 205–209Google Scholar
  59. 59.
    Prince AM, Szmuness W, Millian SJ et al. (1971) A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med 284: 1125–1131PubMedCrossRefGoogle Scholar
  60. 60.
    Quinnan GV Jr, Masur H, Rook AH et al. (1984) Herpesvirus infections in the acquired immune deficiency syndrome. JAMA 252: 72–77PubMedCrossRefGoogle Scholar
  61. 61.
    Ribbert H (1904) Über protozoenartige Zellen in der Niere eines syphilitischen Neugeborenen and in der Parotis von Kindern. Zentralbl Allg Pathol Pathol Anat 15: 945–948Google Scholar
  62. 62.
    Rinaldo CRJ, Black PH, Hirsch MS (1977) Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus. J Infect Dis 136: 667678Google Scholar
  63. 63.
    Rowe WP, Hartley JW, Waterman S, Turner HE, Huebner RJ (1956) Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol Med 92: 418–424PubMedGoogle Scholar
  64. 64.
    Rubin RH (1989) The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA 261: 3607–3609PubMedCrossRefGoogle Scholar
  65. 65.
    Rubin RH, Tolkoff-Rubin NE, Oliver D et al. (1985) Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 40: 243–249PubMedCrossRefGoogle Scholar
  66. 66.
    Saltzman RL, Quirk MR, Jordan MC (1988) Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J Clin Invest 81: 75–81Google Scholar
  67. 67.
    Schrier RD, Nelson JA, Oldstone MBA (1985) Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 230: 1048–1051PubMedCrossRefGoogle Scholar
  68. 68.
    Singh N, Dummer JS, Kusne S et al. (1988) Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 158: 124–131PubMedCrossRefGoogle Scholar
  69. 69.
    Smith D Jr, Wright P, Estes W et al. (1983) Posttransfusion cytomegalovirus infection in neonates weighing less than 1250 grams ( Abstr ). Transfusion 23: 420Google Scholar
  70. 70.
    Smith MG (1954) Propagation of salivary gland virus of the mouse in tissue cultures. Proc Soc Exp Biol Med 86: 435–440PubMedGoogle Scholar
  71. 71.
    Smith MG (1956) Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc Soc Exp Biol Med 92: 424–430PubMedGoogle Scholar
  72. 72.
    Spector SA, Schmidt K, Ticknor W et al. (1979) Cytomegaloviruria in older infants in intensive care nurseries. J Pediatr 95: 444–446PubMedCrossRefGoogle Scholar
  73. 73.
    Spector SA, Rua JA, Spector DH, McMillan RM (1984) Detection of human cytomegalovirus in clinical specimens by DNA—DNA hybridization. J Infect Dis 150: 121126Google Scholar
  74. 74.
    Stagno S, Pass RF, Dworsky ME et al. (1982) Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N Engl J Med 306: 945949Google Scholar
  75. 75.
    Stanier P, Taylor DL, Kitchen AD, Wales N, Tryhorn Y, Tyms AS (1989) Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. Br Med J 299: 897–898CrossRefGoogle Scholar
  76. 76.
    Surgenor D, Wallace E, Hao S, Chapman R (1990) Collection and transfusion of blood in the United States, 1982–1988. N Engl J Med 322: 1646–1651PubMedCrossRefGoogle Scholar
  77. 77.
    Taylor BJ, Jacobs RF, Baker RL, Moses EB, McSwain BE, Shulman G (1986) Frozen deglycerolyzed blood prevents transfusion-acquired cytomegalovirus infections in neonates. Pediatr Infect Dis 5: 188–191PubMedCrossRefGoogle Scholar
  78. 78.
    Tegtmeier GE (1985) Cytomegalovirus and blood transfusion. In: Dodd RY, Barker LF (eds) Infection immunity and blood transfusion. Liss, New York, pp 175–199Google Scholar
  79. 79.
    Tegtmeier GE (1986) Transfusion-transmitted cytomegalovirus infections: significance and control. Vox Sang 51 Suppl 1: 22–30CrossRefGoogle Scholar
  80. 80.
    Tegtmeier GE (1989) Posttransfusion cytomegalovirus infections. Arch Pathol Lab Med 113: 236–245PubMedGoogle Scholar
  81. 81.
    Tolkoff-Rubin NE, Rubin RH, Keller EE (1978) Cytomegalovirus infection in dialysis patients and personnel. Ann Intern Med 89: 625–628PubMedGoogle Scholar
  82. 82.
    Tolpin MD, Stewart JA, Warren D et al. (1985) Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis. J Pediatr 107: 953–956PubMedCrossRefGoogle Scholar
  83. 83.
    Weller TH, Mccauley JC, Craig JM, Wirth P (1957) Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med 94: 4–12PubMedGoogle Scholar
  84. 84.
    Wheeler EO, Turner JD, Scannell JG (1962) Fever, splenomegaly and atypical lymphocytes. N Engl J Med 266: 454–456PubMedCrossRefGoogle Scholar
  85. 85.
    Wilhelm JA, Matter L, Schopfer K (1986) The risk of transmitting cytomegalovirus to patients receiving blood transfusions. J Infect Dis 154: 169–171PubMedCrossRefGoogle Scholar
  86. 86.
    Winston DJ, Gale RP, Meyer DV, Young LS, Group UBMT (1979) Infectious complications of human bone marrow transplantation. Medicine (Baltimore) 58: 1–31Google Scholar
  87. 87.
    Winston DJ, Ho WG, Lin C, Budinger MD, Champlin RE, Gale RP (1984) Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Am J Med 76: 128–133PubMedCrossRefGoogle Scholar
  88. 88.
    Yeager AS (1974) Transfusion-acquired cytomegalovirus infection in newborn infants. Am J Dis Child 128: 478–483PubMedGoogle Scholar
  89. 89.
    Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG (1981) Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 98: 281–287PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • John D. Hamilton
    • 1
  1. 1.Department of MedicineDuke University Medical Center and Department of Veterans Affairs Medical CenterDurhamUSA

Personalised recommendations